C-LANT Drainage Port (190118979)

  https://cordis.europa.eu/project/id/190118979

  Horizon Europe (2021-2027)

  Life Saving Technology for Thoracic Trauma Treatment and Post Operative Drainage

  EIC Accelerator Open (HORIZON-EIC-2022-ACCELERATOROPEN-01)

  mortality  ·  emergency medicine

  2023-03-01 Start Date (YY-MM-DD)

  2025-08-31 End Date (YY-MM-DD)

  € 3,571,250


  Description

Thoracic trauma is the 1st cause of accidental death globally, with a mortality rate of 60% in polytraumatic patients. The time of treatment is crucial. 80% of patients can be potentially saved if they are treated in 1h. However, current solutions to treat it are limited and static for the last 30-50 years. C-LANT is a unique self-fixating, a-traumatic and multifunctional device tackling this unmet need by offering a safe, fast, easy to use, multifunctional and cost-effective tool for treating any type of chest trauma or postoperative drainage following major thoracic and abdominal procedures. It reduces the procedure time by 20x and saves up to €2.6Bn associated with additional tube replacement (EU). With the EIC support Vigor aims to accelerate the clinical validation and scaling-up of C-LANT, providing a global impact to healthcare systems, clinicians, and patients. C-LANT will be part of the growing Emergency Medical Devices and the Surgical Drains markets (total valued >40B -2030)


  Complicit Organisations

1 Israeli organisation participates in C-LANT Drainage Port.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Israel VIGOR MEDICAL TECHNOLOGIES LTD (907632202) IL515105112 coordinator PRC € 3,571,250 € 2,499,875 € 2,499,875